Vaccinations may induce diabetes-related autoantibodies in one-year-old children

Annals of the New York Academy of Sciences

Volumn 1005, Issue , 2003, Pages 404-408

  Wahlberg, J ^a   Fredriksson, J ^a   Vaarala, O ^a   Ludvigsson, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

ABIS; Autoantibodies; BCG vaccination; Children; Diabetes; HIB vaccination

Indexed keywords

AUTOANTIBODY; BCG VACCINE; GLUTAMATE DECARBOXYLASE ANTIBODY; HAEMOPHILUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; BCG VACCINATION; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; INFLUENZA; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZATION; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE;

HAEMOPHILUS; MYCOBACTERIUM BOVIS BCG;

EID: 1942442480     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1288.068     Document Type: Conference Paper

References (25)

1. KARVONEN, M. et al. 2000. Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23: 1516-1526.
2. PUNDZIUTE-LYCKA, A. et al. 2002. Type I diabetes in the 0-34 years group in Sweden. Diabetologia 45: 783-791.
3. BINGLEY, P.J. et al. 1997. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710.
4. SAMUELSSON, U. et al. 2001. Islet autoantibodies in the prediction of diabetes in school children. Diabetes Res. Clin. Pract. 51: 51-57.
5. LINDBERG, B. et al. 1999. Previous exposure to measles, mumps, and rubella - but not vaccination during adolescence - correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics 104: E12.
6. LUDVIGSSON, J. et al. 1988. Mumps with laboratory signs of subclinical pancreatitis may cause a disturbed beta-cell function. Diabetes Res. 9: 193-195.
7. BLOM, L., L. NYSTROM & G. DAHLQUIST. 1991. The Swedish Childhood Diabetes Study: vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 34: 176-181.
8. HYOTY, H. et al. 1993. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland: Childhood Diabetes in Finland Study Group. Diabetologia 36: 1303-1308.
9. DAHLQUIST, G. & L. GOTHEFORS. 1995. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 38: 873-874.
10. HEIJBEL, H., R.T. CHEN & G. DAHLQUIST. 1997. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care 20: 173-175.
11. GRAVES, P.M. et al. 1999. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care 22: 1694-1697.
12. HUMMEL, M. et al. 2000. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 23: 969-974.
13. EURODIAB SUBSTUDY 2 STUDY GROUP. 2000. Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. Diabetologia 43: 47-53.
14. CLASSEN, J.B. 1996. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 24: 137-145.
15. WAHLBERG, J. et al. 2003. Environmental factors related to the induction of beta-cell autoantibodies in 1-year old healthy children. Submitted.
16. KNIP, M. 1997. Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. Ann. Med. 29: 447-451.
17. PARENT, M.E. et al. 1997. Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 20: 767-772.
18. HARADA, M., Y. KISHIMOTO & S. MAKINO. 1990. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res. Clin. Pract. 8: 85-89.
19. SADELAIN, M.W. et al. 1990. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589.
20. SHEHADEH, N. et al. 1994. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343: 706-707.
21. ELIAS, D. et al. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091.
22. BRAS, A. & A.P. AGUAS. 1996. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 89: 20-25.
23. RAZ, I. et al. 2001. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358: 1749-1753.
24. KARVONEN, M., Z. CEPAITIS & J. TUOMILEHTO. 1999. Association between type 1 diabetes and haemophilus influenzae type b vaccination: birth cohort study. BMJ 318: 1169-1172.
25. DESTEFANO, F. et al. 2001. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 108: E112.